Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-10

Clinical Trial Update: RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vernakalant versus procainamide for acute atrial fibrillation in the emergency department has completed. The study is sponsored by the O…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Procainamide (procainamide)
  • Vernakalant (vernakalant)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED